Eric Levine, DPM
Podiatrist · Norwich, CTNPI 1689626020
Payments from drug & device makers
What this record shows
This record is dominated by other: $11,200 of the $12,056 with a category attached, or 92.9%. Convatec Inc. accounts for 93.2% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2024 at $11,485 and has fallen 98.6% since, to $165 in 2025. Among podiatrist clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 36 payments — averaging $334.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Convatec Inc.$11K
- Paratek Pharmaceuticals, Inc.$99
- Triad Life Sciences Inc.$87
- Vertex$66
- Averitas Pharma Inc.$65
- Organogenesis Inc.$62
- plus $442 from 14 others
What the payments were for
- Food & beverage$8567%
- Other$11,20093%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Convatec Inc. | 3 | $11,236 |
| Paratek Pharmaceuticals, Inc. | 5 | $99 |
| Triad Life Sciences Inc. | 3 | $87 |
| Vertex | 2 | $66 |
| Averitas Pharma Inc. | 2 | $65 |
| Organogenesis Inc. | 3 | $62 |
| Reprise Biomedical, Inc. | 2 | $57 |
| Kerecis Limited | 1 | $49 |
| Stryker | 2 | $43 |
| Pfizer | 2 | $42 |
| Mimedx Group, Inc. | 2 | $41 |
| Zimvie Inc. | 1 | $38 |
| AbbVie | 1 | $29 |
| Nevro Corp. | 1 | $28 |
| Solventum Corporation | 1 | $22 |
| EBI, LLC | 1 | $22 |
| Axogen | 1 | $21 |
| DJO, LLC | 1 | $18 |
| Alfasigma USA, Inc. | 1 | $16 |
| Integra Lifesciences Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$11,200
How this compares
$12,056 in reported general payments places this provider in the 95th percentile of 119 podiatrist providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Minocycline Hcl | 35 | $991 |
| Cephalexin | 18 | $367 |
| Gabapentin | 11 | $229 |
| Ciclopirox | 12 | $228 |
| Allopurinol | 17 | $203 |
| Terbinafine Hcl | 13 | $110 |
| Methylprednisolone | 16 | $109 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $55 |
| Meloxicam | 26 | $25 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Norwich
- Edward TarkaNorwich$855
- Peter BlumeNew Haven$481K
- Robert DavisBridgeport$427K
- David NovickiMilford$67K
- Shane ReynoldsNorwalk$14K
- Paul BetschartDanbury$10K
- Michael FeinBethel$9K
- Tehreem SajjadNew Britain$9K
- Christopher YardanWallingford$8K
- Jamie OtfinoskiBethel$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.